Enovis Corporation

Enovis Corporation

ENOVยทNYSE

$21.56

-1.7%
HealthcareMedical - Devices

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

At a Glance

Live Snapshot
Market Cap$1.24B
EPS-20.8600
P/E Ratio-1.03
Earnings Date08/06/2026
3Y-489.0%
5Y-28.0%
10Y-12.0%
3Y+2.0%
5Y+2.0%
10Y+119.0%
3Y-89.0%
5Y-60.0%
10Y-64.0%
ENOV

Enovis Corporation Cash Conversion Engine

ENOV ยท NYSE
Net Income-1.18B
Depreciation & Amortization294.38M
Stock-Based Compensation32.92M
Change in Working Capital15.46M
Others1.06B
Capital Expenditures-197.38M
Free Cash Flow19.92M

Cash Flow Quality Analysis

FCF Conversion Rate

-1.7%

Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.

CapEx Intensity

90.8%

Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.

FCF Growth Trend

+129.6%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

+$15.46M

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

Cash Flow Quality Insight

Capital-intensive growth: Heavy reinvestment limits current cash available but may drive future returns. Assess whether CapEx supports compelling growth opportunities with adequate ROI.

Enovis Corporation Cash Flow Statement

ENOV โ€ข NYSE

Enovis Corporation Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009Dec 2008Dec 2007Dec 2006
OPERATING ACTIVITIES
-1.2B
-824.8M
-33.3M
-11.8M
76.3M
45.8M
-517.1M
154.5M
169.5M
145.2M
187.2M
420.3M
209.1M
-42.3M
4.6M
16.2M
21.7M
-571K
64.9M
94K
294.4M
284.8M
217.1M
219.7M
262.9M
246.2M
236M
141.9M
134.8M
143.3M
154.5M
174.7M
119.3M
200.4M
22.6M
16.1M
15.1M
14.8M
16.9M
13.1M
-2.2M
-10M
-27.4M
6.3M
-22.2M
-29.2M
-590K
-66.6M
12.1M
-1.7M
-22.7M
-139.5M
9.9M
7.2M
-1.7M
-296K
3.6M
-13.4M
22.2M
-6.2M
32.9M
29.7M
34.1M
39M
35.4M
28.9M
22M
25.1M
21.5M
19M
16.3M
17.6M
13.3M
9.4M
4.9M
3.1M
2.6M
11.3M
0.0
0.0
1.1B
647.8M
-28.2M
-88.6M
20.8M
5.2M
522.2M
4.8M
-87M
4.2M
10.1M
9.1M
30.6M
68.7M
22.6M
-518K
613K
-16M
-35K
1M
(0.0)
(10.8M)
(12.5M)
(31.4M)
(47.2M)
(59.4M)
(134.9M)
(97.5M)
(70.7M)
(77.1M)
(79.5M)
(82.7M)
(93.9M)
(70.7M)
-16.7M
(5.8M)
(16.6M)
(18.5M)
(0.0)
(0.0)
15.5M
-13.9M
-27.3M
-220.5M
-17.1M
5M
-131.5M
-33.3M
-32.1M
-63M
-41.6M
-96.4M
-20.1M
-10.4M
4.3M
27.3M
-5.3M
-27.7M
-29.4M
-25.4M
217.3M
113.5M
135M
-55.9M
356.1M
301.9M
130.9M
226.4M
218.8M
247M
303.8M
385.8M
362.2M
164.3M
57.2M
62M
38.3M
-31.5M
74.5M
-17.4M
INVESTING ACTIVITIES
-197.4M
-180.7M
-122.2M
-105.5M
-104.2M
-114.8M
-125.4M
-69.6M
-68.8M
-63.3M
-69.9M
-81.3M
-71.5M
-83.6M
-14.8M
-12.5M
-11M
-20.1M
-13.7M
-10.2M
(16.4M)
-769.9M
-152.8M
-73.7M
-223.3M
-69.8M
-1.5B
-272.5M
(143.5M)
-26M
-196M
-948.8M
-372.5M
-1.9B
-56.3M
-28M
-1.3M
-439K
-33M
(0.0)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
139.5M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6M
-4.8M
32.6M
2.7M
7M
9.6M
7.8M
34.8M
15.1M
7.2M
18.9M
3.1M
-31M
2.3M
1.2M
74K
219K
23K
133K
157K
-179.4M
-955.5M
-242.5M
-176.4M
-320.5M
-175.1M
-1.6B
-167.9M
(89.9M)
-82M
-247M
-1B
-475M
-1.9B
-70M
-40.4M
-12M
-20.5M
-46.5M
-10.1M
FINANCING ACTIVITIES
1.3M
-2.9M
1.8M
5.8M
745.2M
3.5M
11.9M
-195.3M
6.9M
-18.6M
-21.3M
613.9M
324.2M
756.8M
3.7M
912K
0.0
187.3M
0.0
0.0
-43.6M
859.2M
217.2M
-1.6B
-150.4M
-118.3M
1.1B
158.2M
-277.4M
-118.8M
-88.9M
90.9M
-309M
1.1B
29M
-9M
-5.4M
-113.9M
11.7M
26.6M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-3.9M
-20.4M
-17.4M
(0.0)
(0.0)
-38.5B
-38.5M
(0.0)
(0.0)
(0.0)
-4.8M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-200M
(0.0)
-20.8M
-27.4M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-5.7B
-5.7M
(0.0)
(0.0)
-10.1M
-9.5M
-91.2M
1.1B
-9.9M
-16.8M
248.8M
-5.4M
-10M
-5.6M
-15M
-31.4M
-39.8M
-29.3M
0.0
0.0
0.0
0.0
0.0
0.0
-52.4M
846.8M
127.8M
-465.1M
584.9M
-131.7M
1.4B
-47.2M
-280.4M
-145.2M
-131.3M
650M
-45.1M
2.2B
32.7M
-8M
-5.4M
34.8M
11.7M
26.6M
CASH FLOW SUMMARY
2.7M
-1.5M
219K
2.3M
-2.2M
-3.8M
-3.1M
-28.4M
12.1M
4.5M
-33.6M
-11.5M
-13.3M
-8.9M
-5.4M
-2.9M
379K
-2.1M
790K
660K
-11.8M
3.3M
20.5M
-695.1M
618.3M
-8.6M
-135.4M
-17M
40.3M
24.3M
-108M
-5.9M
-171.1M
407.3M
14.6M
10.6M
21.2M
-19.3M
40.5M
-213K
48.2M
44.8M
24.3M
719.4M
101.1M
109.6M
245M
262M
221.7M
197.5M
305.4M
311.3M
482.4M
75.1M
60.5M
50M
28.8M
48.1M
7.6M
7.8M
36.4M
48.2M
44.8M
24.3M
719.4M
101.1M
109.6M
245M
262M
221.7M
197.5M
305.4M
311.3M
482.4M
75.1M
60.5M
50M
28.8M
48.1M
7.6M
19.9M
-67.2M
12.8M
-161.3M
251.9M
187.2M
5.5M
156.7M
150M
183.7M
233.9M
304.4M
290.7M
80.7M
42.4M
49.4M
27.3M
-51.6M
60.8M
-27.6M

SEC Filings

ENOV - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 19, 2026
May 19, 2026
2026
10-Q

10-Q 2026 Q2

Q2

May 07, 2026
April 03, 2026
2026
8-K

8-K 2026

N/A

May 07, 2026
May 07, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 06, 2026
April 06, 2026
2026
10-K

10-K 2025 FY

FY

February 26, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 26, 2026
February 26, 2026
2026
8-K

8-K 2026

N/A

January 12, 2026
January 12, 2026
2026
8-K

8-K 2025

N/A

December 15, 2025
December 10, 2025
2025
8-K

8-K 2025

N/A

December 10, 2025
December 08, 2025
2025
8-K

8-K 2025

N/A

November 14, 2025
November 07, 2025
2025
Showing 1 to 10 of 330 filings